A double-blind placebo controlled study of inhaled Zanamivir for the treatment and prevention of influenza in families had a 79% efficacy in preventing secondary cases when drug was given for 10 days to all exposed family members.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.